AbCellera
Vancouver · Founded 2012
About AbCellera
AbCellera is an antibody discovery and development engine that’s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic – and patients – sooner. With the integrated AbCellera platform, our experts search a wide range of diverse antibodies to select the most effective and developable leads fast and set our partners up for enduring success. We have extensive experience forging partnerships with emerging biotechs and leading pharmaceutical companies. AbCellera leverages proprietary hardware, software, tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
Company Facts
- Founded: 2012
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $10K – $50K
- Total funding: $887.0M
- Funding stage: IPO
- Last round: Grant (May 2023)
- Ticker: nasdaq:ABCL
- Website: abcellera.com
- Phone: (604) 559-9005
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/abcellera-92532 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.